The Role of Cytoprotective Cytokines in Cardiac Ischemia/Reperfusion Injury

Journal of Surgical Research

Volumn 148, Issue 2, 2008, Pages 164-171

  Anderson, Corey D ^a   Heydarkhan Hagvall, Sepideh ^a   Schenke Layland, Katja ^a   Yang, Jin Quan ^a   Jordan, Maria C ^a   Kim, Jeanne K ^a   Brown, David A ^a   Zuk, Patricia A ^a   Laks, Hillel ^a   Roos, Kenneth P ^a   MacLellan, W Robb ^a   Beygui, Ramin E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adult mesenchymal stem cells; hepatocyte growth factor (HGF); ischemia reperfusion injury; myocardium; stromal cell derived factor 1 (CXCL12)

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHEMOKINE CXCL12; HEPATOCYTE GROWTH FACTOR; MALE; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, INBRED LEW; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 46249130081     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.08.005     Document Type: Article

References (35)

1. Tang Y.L., Zhao Q., Qin X., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80 (2005) 229
2. Berry M.F., Engler E.A., Woo Y.J., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290 (2006) H2196
3. Nagaya N., Kangawa K.K., Itoh T., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128
4. Toma C., Pittenger P.M., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93
5. Murry C.E., Soonpaa S.M., Reinecke M.H., et al. Hematopoietic stem cells do not trans-differentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664
6. Rehman J., Traktuev D., Li J., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292
7. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12 (2006) 459
8. Gnecchi M., He H., Noiseux N., et al. Evidence supporting paracrine hypothesis for ACT-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20 (2006) 661
9. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367
10. Wang Y., Ahmad N., Wani M.A., et al. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via ACT pathway and angiogenesis. J Mol Cell Cardiol 37 (2004) 1041
11. Nakamura T., Nawa K., and Ichihara A. A Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122 (1984) 1450
12. Zarnegar R., and Michalopoulos M.G. The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 29 (1995) 1177
13. Ishiki Y., Ohnishi H., Muto Y., et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16 (1992) 1227
14. Kawaida K., Matsumoto K., Shimazu H., et al. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91 (1994) 4357
15. Ohmichi H., Matsumoto K., and Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: Pulmotrophic role in lung regeneration. Am J Physiol 270 (1996) L1031
16. Rappolee D.A., Iyer A., and Patel Y. Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res 78 (1996) 1028
17. Matsumori A., Furukawa Y., Hashimoto T., et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221 (1996) 391
18. Ueda H., Sawa Y., Matsumoto K., et al. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg 67 (1999) 1726
19. Nakamura T., Mizumo S., Matsumoto K., et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106 (2000) 1511
20. Levesque J.P., Hendy J., Takamatsu Y., et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111 (2003) 187
21. Tomita S., Mickle D., Weisel R.D., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123 (2002) 1132
22. Doitsidou M., Reichman-Fried M., Stebler J., et al. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 111 (2002) 647
23. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322
24. Abbott J.D., Huang Y., Liu D., et al. Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300
25. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7 (2001) 211
26. Tanaka N., Dalton N., Mao L., et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94 (1996) 1109
27. Li Y., Takemura G., Kosai K., et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 107 (2003) 2499
28. Urbanek K., Rota M., Cascapera S., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97 (2005) 663
29. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407
30. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494
31. Rangappa S., Fen C., Lee E.H., et al. T Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75 (2003) 775
32. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 7 (2003) 86
33. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomized controlled trial. Lancet 367 (2006) 113
34. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222
35. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355 (2006) 1274